Irish Venture Capital: Sowing the Seeds - - BioPharm International

ADVERTISEMENT

Irish Venture Capital: Sowing the Seeds

BioPharm International


PHARMATRIN LIMITED

Based in Trinity College Dublin, Pharmatrin is developing a novel class of therapeutics known as indane dimers. The target therapeutic areas are organ transplant rejection and autoimmune diseases.

Investment: €1.5 million ($1.8 million)

Source: A consortium of investors that includes Growcorp, the Campus Companies Venture Capital Fund, and the Wellcome Trust. Other investors include Catalyst Biomedica, Trinity Venture Capital, Enterprise Ireland, and Trinity College Dublin.

STOKES BIO LIMITED

Stokes Bio develops microfluidics-based diagnostic systems for the genetic diagnosis of cancer. Childhood leukemia is the initial target disease, around which the microfluidics-based platform technology is developed. The Company is working in close collaboration with the Childhood Cancer Center of St Bartholomew's Hospital London, and the oncology department of the Regional Hospital Limerick.

Investment: €1 million ($1.17 million)

Source: The Cork-based venture capital firm, Kernel Capital Partners.

TriMed RESEARCH INC.

TriMed Research Ltd is an Irish-American biotechnology company based on technology spun out of the University of Nebraska Medical Center. TriMed is focused on therapeutic anti-infective products applied to the prevention of life-threatening infections of low birth weight infants and in immunosuppressed and oncology patients. The technology also has applications in the functional food and veterinary fields.

Investment: €5.0 million ($5.85 million)

Source: Seroba BioVentures and Inventages (Switzerland).

Web site: http://www.trimedres.com/


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines
Source: BioPharm International,
Click here